The future for drug developers is defined by how effectively they adopt innovative strategies and new technologies while navigating industry challenges and complexities.
To assess trends in drug discovery and development, a survey was administered to more than 150 leaders at biotech and pharmaceutical organizations around the globe. The respondents shared the therapeutic areas in their pipelines, barriers to bringing drugs to market, innovations that are driving transformation and attitudes toward key topics such as outsourcing, patient recruitment, diversity and decentralized trials.
In this webinar, the expert speakers will highlight findings from the report and go beyond the data to explain what it means for drug developers across the globe. Attendees will hear about keys to success and prepare themselves to successfully navigate the evolving drug development landscape. They will learn what industry leaders are facing today and how their outlook on pharmaceutical research and development will influence the industry moving forward.
Register for this webinar today to explore the latest trends in drug development and how they are shaping the global pharmaceutical landscape.
Speakers
Debra Schaumberg, VP & Global Head, Strategic Development Consulting, PPD Clinical Research Business of Thermo Fisher Scientific
Schaumberg leads a multi-disciplinary team of more than 70 experts (most holding MD, PhD and/or PharmD degrees) who support biotech and biopharma clients in strategy development and implementation across core disciplines of CMC, toxicology, clinical pharmacology, clinical development and regulatory.
With more than 20 years of experience in the biopharma industry, she has a strong track record of creating and delivering high-quality innovative solutions that address the complex and evolving needs of clients and stakeholders. Schaumberg is responsible for the overall management of the global team, including annual and long-range strategic planning, financial management and people management.
Message Presenter
J. Daniel Jones, Vice President, Project Delivery and Therapeutic Area Head, Cardiovascular and General Medicine CVGM, PPD Clinical Research Business of Thermo Fisher Scientific
Jones serves as Vice President for the PPD Clinical Research Business at Thermo Fisher Scientific, where he leads the Cardiovascular and General Medicine Therapeutic Unit. In this role, he develops and executes business growth strategies and champions enterprise initiatives to expand the therapeutic unit in cardiovascular, metabolic, immunology, dermatology, gastrointestinal, genitourinary, nephrology, and women’s health indications.
Jones joined the business in 1999 and has amassed more than 24 years of experience, holding various roles with increasing responsibility in clinical operations, project management, strategic partnerships, and development operations. Prior to his current position, he served as Vice President and Head of Clinical Operations for the Americas, where he led the regional start-up, clinical monitoring, and clinical administration teams through significant growth. He developed successful recruitment and retention strategies and guided cross-functional initiatives focused on digital and remote solutions. Previously, as a pillar head for development operations leading strategic partnerships, Daniel provided direction in building and driving exceptional delivery and quality across multiple biopharma partnership accounts.
Read more...
Jones has therapeutic area expertise in oncology, hematology, infectious diseases, vaccines, nephrology, dermatology, immunology, cardiovascular, and metabolic disorders. He also has extensive research operations experience in Phase I-IV trials. He holds a bachelor’s degree in biology and chemistry from the University of North Carolina at Chapel Hill.
Read Less...
(Moderator) Praveen Nadella, Head of Customer Insights & Intelligence, PPD Clinical Research Business of Thermo Fisher Scientific
Nadella has more than 20 years of experience in the life sciences industry as both a consultant (IBM, Deloitte, Cognizant) and industry professional (Shionogi, Grifols, GSK). His area of focus and expertise has been predominantly in the area of market research and customer insights and building these competencies within organizations to truly drive customer-driven priorities and actions.
Nadella has driven numerous insights-gathering efforts across multiple stakeholder groups, including patients, clinical trial sponsors, sites/investigators, HCPs, pharmacists and payers. He currently serves as the Head of Customer Insights and Intelligence for the PPD clinical research business of Thermo Fisher Scientific.
Message PresenterWho Should Attend?
This webinar will appeal to Executives and business service team members at biotech and biopharma companies as well as professionals in the following fields:
- Clinical development
- Operations
- Peri-/post approval
- Quality and regulatory
- Preclinical development
- Business services
- Commercial/Marketing
What You Will Learn
Attendees will gain insights into:
- The latest trends in drug discovery and development, including key therapeutic areas, technological advancements and innovative strategies that are driving transformation in the pharmaceutical industry
- The common barriers drug developers face in bringing new therapies to market and strategies to overcome these challenges effectively
- Industry leaders’ perspectives on the future of pharmaceutical research and development
Xtalks Partner
PPD clinical research business of Thermo Fisher Scientific Inc.
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, their capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, they serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, they apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account